Physician Offers Presentation on Minimally Invasive Therapy- Benign Prostate Hypertrophy
September 09, 2009
Urologist, Arnie B. Tannenbaum, M.D. is the featured speaker for an upcoming lecture on Minimally Invasive Therapy- Benign Prostate Hypertrophy, also known as BPH.
Benign prostatic hyperplasia (BPH), also known as benign prostatic hypertrophy, is a non-cancerous enlargement of the prostate. The type and severity of symptoms experienced will vary from person to person and may vary over time. For many men, BPH never progresses beyond a minor to moderate annoyance such as getting up to urinate, going frequently, and uncontrolled urination. For others it may represent a significant challenge to their quality of life. BPH becomes a very common condition in men as they age. According to the American Urology Association, about 50% of men will have some degree of BPH by the time they are 60 years old, and up to 90% will be affected by age 80. Dr. Tannenbaum will be discussing problems associated with BPH, symptoms, diagnosis, and treatment options available.
This presentation is sponsored by Regional Medical Center Bayonet Point and will take place at Regional Medical Center Bayonet Point, Conference Center, 14000 Fivay Road, in Hudson, on Wednesday, September 30 at 3:30 p.m.
This event is free to the public. Refreshments will be served. Due to limited seating, reservations are required, and can be made by calling (727) 869-5498 or 1-888-741-5119.
Regional Medical Center Bayonet Point is a 290-bed acute care facility located in Hudson, FL. Home of the nationally acclaimed Heart Institute, over 350 physicians, 900 employees and 500 volunteers comprise their integrated healthcare delivery team. Regional Medical Center Bayonet Point has been designated a 100 Top Hospital seven years by Thomson Reuters and has been named twice (1999 & 2002) by U.S. News & World Report as one of Americas Best Hospitals in Heart and Heart Surgery. It has an Accredited Chest Pain Center, Joint Commission Accredited Primary Stroke Center and an Approved, With Commendation, Community Cancer Program, from the College of Surgeons.
Marketing & Public Relations Contact: